Formulations of a syrup and tablets based on Asparagus officinalis has an inflammatory effect

Abstract

The present study examines the development of two galenic forms from Asparagus officinalis: a syrup and tablets. Asparagus officinalis is a medicinal plant known for its diuretic, anti- inflammatory, antioxidant, and immunomodulatory properties, attributed to its bioactive components such as saponins, flavonoids, and phenolic acids. The choice of syrup is motivated by its ease of administration, particularly for children and the elderly, while tablets offer increased convenience and stability. The objective is to create effective and stable formulations that preserve the pharmacological properties of the plant. The methodology includes the extraction of active ingredients, product formulation, and evaluation of their stability and efficacy. The preparation of the syrup and tablets involves steps of maceration and vacuum evaporation to extract the active substances, followed by rheology, pH, and compressibility tests to ensure quality and compliance with pharmaceutical standards